REFERENCES
- Sakkas LI. New developments in the pathogenesis of systemic sclerosis. Autoimmunity 2005; 38: 113–116.
- Mayes MD, Lacey JV Jr, Beebe‐dimmer J et al. Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246–2255.
- Matucci‐cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013; 65: 1953–1962.
- Tailor R, Gupta A, Herrick A et al. Ocular manifestations of scleroderma. Surv Ophthalmol 2009; 54: 292–304.
- Farkas TG, Sylvester V, Archer D. The choroidopathy of progressive systemic sclerosis (scleroderma). Am J Ophthalmol 1972; 74: 875–886.
- Serup L, Serup J, Hagdrup H. Fundus fluorescein angiography in generalized scleroderma. Ophthalmic Res 1987; 19: 303–308.
- Spaide RF, Koizumi H, Pozonni MC. Enhanced depth spectral‐domain optical coherence tomography. Am J Ophthalmol 2008; 146: 496–500.
- Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009; 147: 811–815.
- Povazay B, Hermann B, Hofer B et al. Wide‐field optical coherence tomography of the choroid in vivo. Invest Ophthalmol Vis Sci 2009; 50: 1856–1863.
- Subcommittee for scleroderma criteria of the American Rheumatism Association. Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–590.
- Leroy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–205.
- Manjunath V, Taha M, Fujimoto JG et al. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol 2010; 150: 325–329.e1.
- Kim M, Kim SS, Kwon HJ et al. Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci 2012; 53: 7710–7717.
- Grennan DM, Forrester J. Involvement of the eye in SLE and scleroderma. A study using fluorescein angiography in addition to clinical ophthalmic assessment. Ann Rheum Dis 1977; 36: 152–156.
- Kraus A, Guerra‐bautista G, Espinoza G et al. Defects on the retinal pigment epithelium in scleroderma. Br J Rheumatol 1991; 30: 112–114.
- Ingegnoli F, Gualtierotti R, Pierro L et al. Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Microvas Res 2015; 97: 3136.
- Coşkun E, Zengin O, Kenan S et al. Evaluation of choroidal thickness in patients with scleroderma. Eye (Lond) 2016; 30: 588–592.
- Esen E, Tas DA, Sizmaz S et al. Evaluating choroidal characteristics in systemic sclerosis using enhanced depth imaging optical coherence tomography. Ocul Immunol Inflamm 2016; doi: 10.3109/09273948.2015.1129424.
- Vancheeswaran R, Magoulas T, Efrat G et al. Circulating endothelin‐1 levels in systemic sclerosis subsets–a marker of fibrosis or vascular dysfunction? J Rheumatol 1994; 21: 1838–1844.
- Grieshaber MC, Mozaffarieh M, Flammer J. What is the link between vascular dysregulation and glaucoma? Surv Ophthalmol 2007; 52 (Suppl 2): S144–S154.
- Rabquer BJ, Koch AE. Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts. Curr Rheumatol Rep 2012; 14: 56–63.
- Ulaş F, Çelik F, Doğan Ü et al. Effect of smoking on choroidal thickness in healthy smokers. Curr Eye Res 2014; 39: 504–411.
- Branchini L, Regatieri CV, Flores‐moreno I et al. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012; 119: 119–123.
- Tian J, Marziliano P, Baskaran M et al. Automatic measurements of choroidal thickness in EDI‐OCT images. Conf Proc IEEE Eng Med Biol Soc 2012; 2012: 5360–5363.